Showing results (621-630 of 977) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|September 5, 2019
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancerSwati Gupta, Veronique Neumeister, John McGuire, et al.
NPJ Breast Cancer|July 6, 2021
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East AsiaChing-Hung Lin, Ruby Yun-Ju Huang, Tzu-Pin Lu, et al.
NPJ Breast Cancer|May 31, 2023
Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysisLili Chen, Fan Wu, Xiaobin Chen, et al.
NPJ Breast Cancer|May 31, 2023
Multigene profiles to guide the use of neoadjuvant chemotherapy for breast cancer: a Copenhagen Breast Cancer Genomics StudyM-B Jensen, C B Pedersen, M-A Misiakou, et al.
NPJ Breast Cancer|June 8, 2023
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancerLuca Licata, Giulia Viale, Mario Giuliano, et al.
NPJ Breast Cancer|May 27, 2026
Risk factors for second primary cancer in patients who survive breast cancerPhillip Park, Keunkyun Kim, Dong-Woo Choi, et al.
NPJ Breast Cancer|May 29, 2026
Preoperative onapristone-XR in postmenopausal women with progesterone receptor-positive (PgR+)/HER2-negative early breast cancer: SOLTI-1802 ONAWA trial resultsMeritxell Bellet, Juan M Ferrero-Cafiero, Milana Bergamino Sirvén, et al.
NPJ Breast Cancer|December 12, 2025
Stromal fibroblastic mutant Trp53 promotes mammary tumor development via enhanced secretion of paracrine factorsBin Liu, Shunbin Xiong, Abie Williams-Villalobo, et al.
NPJ Breast Cancer|April 13, 2026
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancerMarion T Van Mackelenbergh, Nicole Pfarr, Karsten Weber, et al.
NPJ Breast Cancer|April 27, 2026
Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trialJoyce O'Shaughnessy, Francois-Clement Bidard, Patrick Neven, et al.
Pageof 98